Teva launches copy of asthma inhaler Advair

April 20 (Reuters) - Teva Pharmaceutical Industries Ltd launched its asthma inhaler and the authorized generic of the drug on Thursday, nearly three months after it got U.S. approval to market a copy of GlaxoSmithKline's best-selling Advair.